Tranche Update on Dong-A ST Co., Ltd.'s Equity Buyback Plan announced on July 26, 2023.
October 19, 2023 at 03:46 am EDT
Share
From October 1, 2023 to October 17, 2023, the company has repurchased 12,081 shares, representing 0.14% for KRW 739.7 million. With this, the company has completed the repurchase of 38,373 shares, representing 0.45% for KRW 2,296.31 million under the buyback announced on July 26, 2023.
Dong-A ST Co Ltd is a Korea-based company mainly engaged in the production and sale of pharmaceuticals. The Company is involved of the manufacturing and sale of gastric mucosal protective agents, antihistamines, ischemic modifiers, antithrombotic agents, functional dyspepsia, hyperlipidemia, growth hormone, peptic ulcer treatments, cerebral metabolism improvement and hypertension treatments. It produces and sells diagnostic reagents for hepatitis E, I, A and B. In addition, it is engaged in the production and sale of medical devices including implants for artificial joint and maxillofacial surgery. The Company distributes its products in domestic and overseas markets such as Brazil, Turkey and Cambodia.
DONG-A ST CO., LTD. 
